健脾醒酒方通过抑制Toll样受体4/核因子κB通路改善轻中度酒精中毒: 一项随机对照研究

Jianpi Xingjiu Formula in improving mild-moderate alcohol intoxication by inhibition of Toll-like receptor 4/nuclear factor-κB pathway: a randomized controlled trial

  • 摘要:
    目的 探讨健脾醒酒方对轻中度急性酒精中毒患者的催醒及护肝作用, 并初步分析其可能机制。
    方法 选取98例轻中度酒精中毒患者作为研究对象,并随机分为治疗组(口服健脾醒酒方, n=49)和对照组(静脉注射盐酸纳洛酮,n=49)。比较2组患者的催醒时间、症状完全消失时间以及中医症状积分。检测2组血液中肝功能指标谷丙转氨酶(ALT)、谷草转氨酶(AST)、γ-谷氨酰转肽酶(GGT)、酒精浓度、超氧化物歧化酶(SOD)、脂多糖(LPS)及炎症因子肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平,并评估临床总有效率。采用乙醇-LPS联合诱导AML-12细胞建立体外肝损伤模型,观察细胞形态、细胞活力、乳酸脱氢酶(LDH)释放情况及Toll样受体4(TLR4)/核因子κB(NF-κB)通路蛋白表达。
    结果 2组催醒时间比较,差异无统计学意义(P>0.05), 但治疗组症状完全消失时间短于对照组,差异有统计学意义(P < 0.05)。治疗后,治疗组的头晕/头痛、疲乏无力、口干口苦症状积分低于对照组,差异有统计学意义(P < 0.05)。治疗后, 治疗组ALT、AST、GGT低于对照组,差异有统计学意义(P < 0.01)。治疗后,治疗组血液酒精浓度低于对照组, SOD水平高于对照组,差异有统计学意义(P < 0.05)。治疗后, 2组患者血液LPS、TNF-α及IL-6水平低于治疗前,且治疗组低于对照组,差异有统计学意义(P < 0.05或P < 0.01)。治疗组总有效率为93.75%, 高于对照组的65.96%, 差异有统计学意义(P < 0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。体外实验显示,健脾醒酒方可显著改善肝细胞形态、增强细胞活力、减少LDH释放,并抑制TLR4/NF-κB信号通路的过度激活。
    结论 健脾醒酒方能有效缓解轻中度酒精中毒临床症状,促进症状消失,改善肝功能及氧化应激状态,其作用机制可能与抑制TLR4/NF-κB炎症通路有关。

     

    Abstract:
    Objective To investigate the waking-up and liver-protective effects of Jianpi Xingjiu Formula in patients with mild to moderate acute alcohol intoxication and to preliminarily analyze its potential mechanisms.
    Methods A total of 98 patients with mild to moderate alcohol intoxication were selected as the study subjects, and randomly divided into treatment group (oral administration of Jianpi Xingjiu Formula, n=49) and control group (intravenous injection of naloxone hydrochloride, n=49). The waking-up time, the time for complete disappearance of symptoms and traditional Chinese medicine symptom scores were compared between the two groups. The levels of liver function indicators alanine aminotransferase (ALT), aspartate aminotransferase (AST) and γ-glutamyl transpeptidase (GGT), blood ethanol concentration, superoxide dismutase (SOD), lipopolysaccharide (LPS) and inflammatory factors tumor necrosis factor-α(TNF-α) and interleukin-6 (IL-6) in the blood of the two groups were measured, and the overall clinical effective rate was evaluated. An in vitro liver injury model was established by inducing AML-12 cells with a combination of ethanol and LPS. Cell morphology, cell viability, the release of lactate dehydrogenase (LDH) and the protein expressions of the Toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway were observed.
    Results There was no statistically significant difference in the waking-up time between the two groups (P>0.05), but the time for complete disappearance of symptoms in the treatment group was significantly shorter than that in the control group (P < 0.05). After treatment, the scores of symptoms such as dizziness/headache, fatigue and dry/bitter mouth in the treatment group were significantly lower than those in the control group (P < 0.05). After treatment, the levels of ALT, AST and GGT in the treatment group were significantly lower than those in the control group (P < 0.01). After treatment, the blood alcohol concentration in the treatment group was significantly lower than that in the control group, while the SOD level was significantly higher (P < 0.05). After treatment, the levels of LPS, TNF-α and IL-6 in the blood of patients in both groups were significantly lower than those before treatment, and those in the treatment group were significantly lower than those in the control group (P < 0.05 or P < 0.01). The overall effective rate in the treatment group was 93.75%, which was significantly higher than the 65.96% in the control group (P < 0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). In vitro experiments showed that Jianpi Xingjiu Formula could significantly improve hepatocyte morphology, enhance cell viability, reduce LDH release, and inhibit the overactivation of the TLR4/NF-κB signaling pathway.
    Conclusion Jianpi Xingjiu Formula can effectively alleviate the clinical symptoms of mild to moderate alcohol intoxication, promote the disappearance of symptoms, and improve liver function and oxidative stress status. Its mechanism of action may be related to the inhibition of the TLR4/NF-κB inflammatory pathway.

     

/

返回文章
返回